|4Feb 16, 4:36 PM ET

Aulick Rodney 4

4 · Xylem Inc. · Filed Feb 16, 2024

Insider Transaction Report

Form 4
Period: 2024-02-14
Aulick Rodney
EVP & President, WSS
Transactions
  • Exercise/Conversion

    Common Stock

    2024-02-14$43.50/sh+23,870$1,038,345104,365 total
  • Sale

    Common Stock

    2024-02-14$122.55/sh23,870$2,925,15980,495 total
  • Exercise/Conversion

    Non-Qualified Stock Option (Right to Buy)

    2024-02-1423,87023,870 total
    Exercise: $43.50Exp: 2028-04-02Common Stock (23,870 underlying)
Footnotes (2)
  • [F1]This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 23,870 Shares were executed at a range of prices from $122.45 to $123.4499. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.
  • [F2]The April 2, 2018 option grant vested one fourth on January 1, 2019, January 1, 2020, January 1, 2021, and January 1, 2022.

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT